| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 225.84M | 266.74M | 177.67M | 160.91M | 248.78M |
| Gross Profit | 65.43M | 78.86M | 41.67M | 31.64M | 65.66M |
| EBITDA | 9.37M | 17.43M | -17.93M | -48.84M | -29.05M |
| Net Income | -55.32M | -16.73M | -45.27M | -70.94M | -6.55M |
Balance Sheet | |||||
| Total Assets | 623.27M | 644.80M | 588.08M | 571.50M | 593.73M |
| Cash, Cash Equivalents and Short-Term Investments | 21.05M | 14.15M | 3.65M | 10.73M | 12.76M |
| Total Debt | 227.57M | 172.71M | 133.59M | 144.24M | 144.79M |
| Total Liabilities | 325.15M | 289.27M | 275.40M | 281.56M | 248.00M |
| Stockholders Equity | 297.00M | 354.41M | 311.55M | 288.88M | 344.66M |
Cash Flow | |||||
| Free Cash Flow | -26.89M | -56.57M | -6.73M | -7.32M | -52.63M |
| Operating Cash Flow | 31.13M | 5.21M | 9.56M | 28.89M | 27.27M |
| Investing Cash Flow | -57.68M | -57.63M | -10.10M | -36.37M | -71.88M |
| Financing Cash Flow | 39.34M | 56.42M | -2.29M | 5.11M | 5.06M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$162.00M | 1.58 | 22.49% | 7.89% | 14.30% | 125.41% | |
63 Neutral | HK$409.52M | 7.23 | 2.16% | 2.33% | -8.16% | -23.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.06B | 5.21 | 5.79% | 6.04% | -1.81% | -2.23% | |
51 Neutral | HK$375.70M | -51.74 | -1.02% | 4.55% | -14.46% | 44.09% | |
49 Neutral | HK$358.99M | -9.67 | -40.73% | ― | 56.41% | -88.86% | |
46 Neutral | HK$823.83M | -11.23 | -17.17% | ― | -13.06% | -197.89% |